U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864104) titled 'A Study to Investigate Tonlamarsen for the Treatment of Adults with Uncontrolled Hypertension' on Feb. 12.
Brief Summary: The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who, despite taking 2 or more antihypertensive medications, have not achieved their target blood pressure (BP).
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: Tonlamarsen
Tonlamarsen will be administered subcutaneously (SC) every 4 weeks during the randomized part of the study
DRUG: Placebo
Placebo will be administered subcutaneously (SC) ever...